Click here to submit an event to share with the GES Community.
- This event has passed.
Rodolphe Barrangou – Catching up with the CRISPR craze | GES Colloquium (Zoom)
September 29, 2020 @ 12:00 pm - 1:00 pm EDT
Catching up with the CRISPR craze: applications and implications of genome editing technologies
Speaker: Rodolphe Barrangou, PhD, Todd R. Klaenhammer Distinguished Professor, FBNS, at NC State
A discussion of the applications and implications of CRISPR-based technologies in Food, Ag, and beyond.
Note: Colloquium will be held via Zoom until the university resumes normal operations. Click Register/Join button at the bottom of this page for Zoom link. See Virtual Colloquium: Zoom Instructions for Zoom information.
The advent of CRISPR-based technologies has revolutionized our ability to manipulate the genetic content of organisms across the tree of life, and democratized genome editing across the globe. Actually, genome editing technologies have been broadly deployed in academia and industry in the past 8 years, to manipulate the genomes of organisms relevant to medicine, biotechnology and agriculture. I will look back on the historical milestones that have paved the way for the CRISPR era, and discuss the diverse applications that have impacted and continue to shape the food and Ag supply chain, encompassing food fermentation, crops, livestock and forests. Given the business potential of this disruptive technology, it is important to also account for regulatory frameworks, public engagement, investment opportunities and competitive landscape implications.
- CRISPR Journal
- CRISPRcon (GES-led sessions on October 13 & 15 – Equity, Environment & Agriculture) – Register for these discussions
Rodolphe Barrangou Ph.D. is the T. R. Klaenhammer Distinguished Professor in Probiotics Research at North Carolina State University. Barrangou is focusing on the characterization of CRISPR-Cas systems, and their applications in bacteria. Rodolphe spent 9 years in R&D and M&A at DuPont. For his CRISPR work, Rodolphe received several international awards, and has been elected into the National Academy of Sciences and the National Academy of Engineering. Dr. Barrangou is also the former Chairman of the Board of Caribou Biosciences, a co-founder of Intellia Therapeutics, Locus Biosciences, TreeCo and CRISPR biotechnologies, and the Editor in Chief of the CRISPR Journal.